AR051595A1 - Composiciones farmaceuticas a base de nk2 antagonista para uso pediatrico - Google Patents
Composiciones farmaceuticas a base de nk2 antagonista para uso pediatricoInfo
- Publication number
- AR051595A1 AR051595A1 ARP050104429A ARP050104429A AR051595A1 AR 051595 A1 AR051595 A1 AR 051595A1 AR P050104429 A ARP050104429 A AR P050104429A AR P050104429 A ARP050104429 A AR P050104429A AR 051595 A1 AR051595 A1 AR 051595A1
- Authority
- AR
- Argentina
- Prior art keywords
- piperidin
- dichlorophenyl
- cycle
- ylmethyl
- phenyl
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 239000002746 neurokinin 2 receptor antagonist Substances 0.000 title abstract 2
- -1 benzo [b] thiophenyl-2-ylcarbonyl Chemical group 0.000 abstract 12
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 abstract 7
- 239000005557 antagonist Substances 0.000 abstract 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 3
- 125000005605 benzo group Chemical group 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 abstract 2
- PGKXDIMONUAMFR-AREMUKBSSA-N saredutant Chemical compound C([C@H](CN(C)C(=O)C=1C=CC=CC=1)C=1C=C(Cl)C(Cl)=CC=1)CN(CC1)CCC1(NC(C)=O)C1=CC=CC=C1 PGKXDIMONUAMFR-AREMUKBSSA-N 0.000 abstract 2
- 125000003003 spiro group Chemical group 0.000 abstract 2
- KQOZGMVAKCVJHO-UHFFFAOYSA-N 5-iodo-1-benzofuran-2-carboxylic acid Chemical compound IC1=CC=C2OC(C(=O)O)=CC2=C1 KQOZGMVAKCVJHO-UHFFFAOYSA-N 0.000 abstract 1
- OQIMJOXSDVGEBU-UHFFFAOYSA-N 6-bromo-1-benzothiophene Chemical compound BrC1=CC=C2C=CSC2=C1 OQIMJOXSDVGEBU-UHFFFAOYSA-N 0.000 abstract 1
- 208000004998 Abdominal Pain Diseases 0.000 abstract 1
- 208000002881 Colic Diseases 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 1
- 101000713585 Homo sapiens Tubulin beta-4A chain Proteins 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 108010092101 MEN 11420 Proteins 0.000 abstract 1
- 102100036788 Tubulin beta-4A chain Human genes 0.000 abstract 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 abstract 1
- 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 abstract 1
- 125000001488 beta-D-galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 abstract 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 abstract 1
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 abstract 1
- NGCNKEZHGRXHNL-WVWQGFTISA-N n-[(2r,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-2-[(1s,4s,7s,10s,13s,16s)-13-benzyl-16-(1h-indol-3-ylmethyl)-7-(2-methylpropyl)-3,6,9,12,15,18,20-heptaoxo-2,5,8,11,14,17,21-heptazabicyclo[8.8.4]docosan-4-yl]acetamide Chemical compound C([C@H]1C(=O)N[C@H]2CC(=O)NC[C@H](NC(=O)[C@H](CC=3C=CC=CC=3)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC2=O)C(=O)N[C@H](C(N1)=O)CC(C)C)C(=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O NGCNKEZHGRXHNL-WVWQGFTISA-N 0.000 abstract 1
- RMRHFQVHSFCBEO-UHFFFAOYSA-N n-[2-(3,4-dichlorophenyl)-4-(3-oxospiro[2,4-dihydroisoquinoline-1,4'-piperidine]-1'-yl)butyl]-3,4,5-trimethoxy-n-methylbenzamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N(C)CC(CCN2CCC3(CC2)C2=CC=CC=C2CC(=O)N3)C=2C=C(Cl)C(Cl)=CC=2)=C1 RMRHFQVHSFCBEO-UHFFFAOYSA-N 0.000 abstract 1
- 229950000640 nepadutant Drugs 0.000 abstract 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- LEWDKQKVAFOMPI-UHFFFAOYSA-N quinoline-4-carboxamide Chemical compound C1=CC=C2C(C(=O)N)=CC=NC2=C1 LEWDKQKVAFOMPI-UHFFFAOYSA-N 0.000 abstract 1
- 229950004387 saredutant Drugs 0.000 abstract 1
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002462 tachykinin receptor antagonist Substances 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000221A ITFI20040221A1 (it) | 2004-10-27 | 2004-10-27 | Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051595A1 true AR051595A1 (es) | 2007-01-24 |
Family
ID=35613882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050104429A AR051595A1 (es) | 2004-10-27 | 2005-10-24 | Composiciones farmaceuticas a base de nk2 antagonista para uso pediatrico |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7727955B2 (enExample) |
| EP (1) | EP1809267B1 (enExample) |
| JP (1) | JP2008517977A (enExample) |
| CN (1) | CN101052386A (enExample) |
| AR (1) | AR051595A1 (enExample) |
| AT (1) | ATE422881T1 (enExample) |
| AU (1) | AU2005298629B2 (enExample) |
| CA (1) | CA2584481C (enExample) |
| CY (1) | CY1109803T1 (enExample) |
| DE (1) | DE602005012857D1 (enExample) |
| DK (1) | DK1809267T3 (enExample) |
| EA (1) | EA012264B1 (enExample) |
| ES (1) | ES2325413T3 (enExample) |
| HR (1) | HRP20090225T1 (enExample) |
| IT (1) | ITFI20040221A1 (enExample) |
| MX (1) | MX2007004461A (enExample) |
| NO (1) | NO338586B1 (enExample) |
| NZ (1) | NZ555380A (enExample) |
| PL (1) | PL1809267T3 (enExample) |
| PT (1) | PT1809267E (enExample) |
| RS (1) | RS50780B (enExample) |
| SI (1) | SI1809267T1 (enExample) |
| UA (1) | UA91988C2 (enExample) |
| WO (1) | WO2006045820A1 (enExample) |
| ZA (1) | ZA200703909B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0614970D0 (en) * | 2006-07-27 | 2006-09-06 | R & D Sosei Ltd | Compounds For Use In Therapy |
| IT1394304B1 (it) * | 2009-05-21 | 2012-06-06 | Malesci Sas | Processo per la preparazione di ibodutant (men15596) e relativi intermedi |
| ITRM20120331A1 (it) * | 2012-07-12 | 2014-01-13 | Guidotti & C Spa Labor | Composizioni pediatriche orali liquide contenenti nepadutant. |
| US20160051596A1 (en) * | 2014-08-21 | 2016-02-25 | Food Industry Research And Development Institute | Novel acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase |
| US9867857B2 (en) | 2014-08-21 | 2018-01-16 | Food Industry Research And Development Institute | Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0219318A (ja) * | 1988-06-30 | 1990-01-23 | Carl R Thornfeldt | 疝痛及び生歯に対する治療 |
| IT1277835B1 (it) * | 1995-03-13 | 1997-11-12 | Menarini Farma Ind | Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche |
| IT1307809B1 (it) * | 1999-10-21 | 2001-11-19 | Menarini Ricerche Spa | Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono. |
| MY130373A (en) * | 2001-10-29 | 2007-06-29 | Malesci Sas | Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| GB0224788D0 (en) * | 2002-10-24 | 2002-12-04 | Novartis Ag | Organic compounds |
-
2004
- 2004-10-27 IT IT000221A patent/ITFI20040221A1/it unknown
-
2005
- 2005-10-24 AR ARP050104429A patent/AR051595A1/es unknown
- 2005-10-26 CA CA2584481A patent/CA2584481C/en not_active Expired - Fee Related
- 2005-10-26 DK DK05810894T patent/DK1809267T3/da active
- 2005-10-26 RS RSP-2009/0169A patent/RS50780B/sr unknown
- 2005-10-26 ES ES05810894T patent/ES2325413T3/es not_active Expired - Lifetime
- 2005-10-26 EP EP05810894A patent/EP1809267B1/en not_active Expired - Lifetime
- 2005-10-26 JP JP2007538414A patent/JP2008517977A/ja active Pending
- 2005-10-26 PL PL05810894T patent/PL1809267T3/pl unknown
- 2005-10-26 EA EA200700949A patent/EA012264B1/ru not_active IP Right Cessation
- 2005-10-26 AU AU2005298629A patent/AU2005298629B2/en not_active Ceased
- 2005-10-26 SI SI200530661T patent/SI1809267T1/sl unknown
- 2005-10-26 US US11/666,204 patent/US7727955B2/en not_active Expired - Fee Related
- 2005-10-26 WO PCT/EP2005/055575 patent/WO2006045820A1/en not_active Ceased
- 2005-10-26 UA UAA200705837A patent/UA91988C2/ru unknown
- 2005-10-26 MX MX2007004461A patent/MX2007004461A/es active IP Right Grant
- 2005-10-26 HR HR20090225T patent/HRP20090225T1/xx unknown
- 2005-10-26 PT PT05810894T patent/PT1809267E/pt unknown
- 2005-10-26 AT AT05810894T patent/ATE422881T1/de active
- 2005-10-26 NZ NZ555380A patent/NZ555380A/en not_active IP Right Cessation
- 2005-10-26 CN CNA2005800370703A patent/CN101052386A/zh active Pending
- 2005-10-26 DE DE602005012857T patent/DE602005012857D1/de not_active Expired - Lifetime
-
2007
- 2007-05-15 ZA ZA200703909A patent/ZA200703909B/xx unknown
- 2007-05-29 NO NO20072720A patent/NO338586B1/no not_active IP Right Cessation
-
2009
- 2009-05-07 CY CY20091100493T patent/CY1109803T1/el unknown
-
2010
- 2010-04-19 US US12/799,176 patent/US20100234284A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO20072720L (no) | 2007-07-09 |
| US20080090795A1 (en) | 2008-04-17 |
| CN101052386A (zh) | 2007-10-10 |
| EA200700949A1 (ru) | 2007-10-26 |
| ITFI20040221A1 (it) | 2005-01-27 |
| ATE422881T1 (de) | 2009-03-15 |
| NO338586B1 (no) | 2016-09-12 |
| HRP20090225T1 (hr) | 2009-05-31 |
| EP1809267B1 (en) | 2009-02-18 |
| RS50780B (sr) | 2010-08-31 |
| CY1109803T1 (el) | 2014-09-10 |
| EP1809267A1 (en) | 2007-07-25 |
| PT1809267E (pt) | 2009-05-28 |
| DE602005012857D1 (de) | 2009-04-02 |
| SI1809267T1 (sl) | 2009-06-30 |
| AU2005298629B2 (en) | 2011-02-17 |
| MX2007004461A (es) | 2007-07-11 |
| ZA200703909B (en) | 2008-09-25 |
| UA91988C2 (ru) | 2010-09-27 |
| DK1809267T3 (da) | 2009-05-18 |
| CA2584481C (en) | 2014-07-15 |
| AU2005298629A1 (en) | 2006-05-04 |
| PL1809267T3 (pl) | 2009-07-31 |
| US20100234284A1 (en) | 2010-09-16 |
| ES2325413T3 (es) | 2009-09-03 |
| HK1109335A1 (en) | 2008-06-06 |
| US7727955B2 (en) | 2010-06-01 |
| WO2006045820A1 (en) | 2006-05-04 |
| JP2008517977A (ja) | 2008-05-29 |
| EA012264B1 (ru) | 2009-08-28 |
| NZ555380A (en) | 2008-12-24 |
| CA2584481A1 (en) | 2006-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2487127C2 (ru) | Хиральные цис-имидазолины | |
| RU2470022C2 (ru) | Оксазолидиновые антибиотики | |
| HRP20110640T1 (hr) | Derivati cikličkih amida i njihova proizvodnja te njihova uporaba kao antitromboznih sredstava | |
| US6818658B2 (en) | Acylated piperidine derivatives as melanocortin-4 receptor agonists | |
| RU2437882C2 (ru) | Производные имидазолидинона | |
| ES2272703T3 (es) | Derivados de piperidina acilados como agonistas de receptor de melanocortina-4. | |
| ES2348122T3 (es) | Derivados de diazepano moduladores de receptores de quimioquina. | |
| RU2011115111A (ru) | Замещенные пирролидин-2-карбоксамиды | |
| WO2005113542B1 (en) | N-cyclic sulfonamido inhibitors of gamma secretase | |
| RU2000129161A (ru) | Производное 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способ его получения, фармацевтическая композиция, содержащая указанное соединение, и промежуточный продукт | |
| EA001559B1 (ru) | Производные 1-(1,2-дизамещенный пиперидинил)-4-замещенного пиперидина как антагонисты рецепторов тахикинина | |
| ES2319642T3 (es) | Derivados 1,4-di-piperidina-4-il-piperazina sustituidos y su uso como antagonistas de la neuroquinina. | |
| PE20060598A1 (es) | Derivado heterociclo conteniendo nitrogeno como antagonista de quimiocina ccr5 | |
| RU2003107016A (ru) | Замещенные пиразолы | |
| RU2008120619A (ru) | (гетеро)арилы, обладающие антагонистической активностью по отношению к меланинконцентрирующему гормону | |
| EP1581517B1 (en) | Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists | |
| AR051595A1 (es) | Composiciones farmaceuticas a base de nk2 antagonista para uso pediatrico | |
| NZ541035A (en) | Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists | |
| PE20050470A1 (es) | 5-arilpirimidinas como agentes anticancerigenos | |
| RU2008147542A (ru) | Агонисты мускариновых рецепторов, эффективные при лечении боли, болезни альцгеймера и шизофрении | |
| RU2015144485A (ru) | Геминально-замещенные цианоэтилпиразолопиридоны в качестве ингибиторов janus киназ | |
| RU2006100730A (ru) | Цис-2, 4, 5-триарил-имидазолины | |
| WO2004110415A2 (en) | Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments | |
| CA2569861A1 (en) | Pyrrolidine derivatives as ccr5 antagonists | |
| AU2004228960A1 (en) | Substituted 4-phenyl-4-`1H-imidazol-2-yl !-piperidine derivatives and their use as selective non-peptide delta opioid agonists with antidepressant and anxiolytic activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |